• Medy-Tox corrected its stock retirement filing, delaying the planned cancellation date for 440,635 redeemable convertible preferred shares to Dec. 24, 2026.
• The company had already redeemed the full RCPS issue, paying KRW 76.72 billion on Feb. 23, 2026.
• Electronic registration cancellation is delayed because an account transfer process for a former shareholder has not been completed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medy-Tox Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930900177), on September 30, 2026, and is solely responsible for the information contained therein.